AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,530.00
+350.00 (4.28%)
Oct 11, 2024, 9:00 AM KST

AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 1.12B KRW in the quarter ending June 30, 2024, with 16,414.26% growth. This brings the company's revenue in the last twelve months to 2.06B. In the year 2023, AptaBio Therapeutics had annual revenue of 323.87M with 569.80% growth.

Revenue (ttm)
2.06B
Revenue Growth
+569.80%
P/S Ratio
92.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
210.95B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition